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1. Introduction 
The 12,13-epoxytrichothecenes inhibit protein 
synthesis in eukaryotic organisms [l] and can block 
peptidyl transferase activity as assayed by the puro- 
mycin fragment reaction [2]. However, on the basis 
of experiments in vivo they have been divided into 
two subgroups [3]. It has been proposed that com- 
pounds in one subgroup (I-type inhibitors) which 
include T-2 toxin, act at some stage of the initiation 
process. Compounds in the second subgroup (E-type 
inhibitors) include trichodermin and seem to inhibit 
elongation or perhaps more specifically termination 
[41. 
The 12,13-epoxytrichothecenes are closely related 
chemically [5] and it has been suggested thai they 
have the same site of action on ribosomes [6]. It remains, 
therefore, to establish why the two subgroups apparent- 
ly act at different stages of the protein synthetic cycle. 
Recent work with trichodermin has strongly suggested 
that this compound acts as a general inhibitor of the 
peptidyl transferase catalytic centre [6] and it is tempt- 
ing to assume that T-2 toxin also inhibits this same 
enzymic centre but, for some reason, only at the ini- 
tiation step of protein synthesis. 
In this present work we have utilized the reticulocyte 
cell-free system to study the effect of T-2 toxin on 
the initiation process. We have found that T-2 toxin 
can inhibit the reaction which can take place between 
puromycin and met-tRNAmft bound to the 80 S ribo- 
some. 
2. Materials and methods 
2.1. Preparation of rabbit reticulocy te lysates 
Blood from anaemic young male New Zealand white 
rabbits was collected in ice-cold 100 ml glass centrifuge 
tubes. The reticulocytes were harvested from the blood 
and then washed three times in 130 mM NaCl-5 mM 
KCl-7.5 mM magnesium acetate before resuspension 
(original volume of the packed cells) in 4 mM magnesium 
acetate-l mM dithiothreitol. After gentle stirring for 
5 min unlysed cells and debris were removed by centri- 
fugation for 20 min at 12 000 rev/min in a M.&E. 18 
centrifuge. The supernate (1: 1 lysate) was decanted and 
stored in 1 ml aliquots in liquid nitrogen. 
2.2. Cell-free protein synthesis in reticulocyte lysates 
Cell-free protein synthesis was assayed by adding 
125 ~1 of 1: 1 lysate to an equal volume of incubation 
mix (pH 7.2) so that the final concentrations of materials 
were 80 mM KCl, 20 mM Tris-Cl buffer, pH 7.2 at 
2O”C, 3 mM magnesium acetate, 1 mM dithiothreitol, 
0.1 mM EDTA, 20 mM creatine phosphate, 1 mM 
ATP, 1.6 mM GTP, 2 X 10m2 mM of unlabelled amino 
acids without valine, 4 E.cCi of LJ2,3- [” H] ) valine-spe- 
cific activity 3 1.6 Ci/mmol and 5 I.cg of creatine kinase. 
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The mixture was incubated at 36°C and at appropriate 
times 20 ~1 aliquots were withdrawn, pipetted on to 
2.5 cm discs of Whatman 3mm paper and placed in a 
beaker of icecold acetone containing 1% (v/v) HCl to 
precipitate protein and remove haem. 30 min after 
the addition of the last disc to the beaker, the discs 
were removed and placed into 5% trichloroacetic acid 
preheated to 95°C. After 20 min at 95’C the discs were 
removed and washed twice with each of ice-cold 5% 
trichloroacetic acid, ethanol-ether (3: 1 v/v) and ether. 
After drying, the discs were counted in a liquid scin- 
tillation counter. 
2.3. Preparation of 0.5 M KC2 ribosomal wash 
Reticulocyte 0.5 M KC1 ribosomal wash was prepar- 
ed from total reticulocyte ribosome pellets as described 
by Schreier and Staehelin [7]. 
2.4. Preparation of 0.5 M KC1 derived ribosomal 
subunits from Krebs ascites tumour cells 
Krebs ascites cells were grown for seven to eight days 
in male Schofield mice. The cells were harvested and 
ribosomal subunits were prepared by sucrose gradient 
centrifugation of cell homogenates a  described previ- 
ously [8] . 
2.5. Preparation and analysis of r3’S] methionyl- 
tRA!A”~ 
Partially purified preparations of Escherichia coli 
aminoacyl-tRNA synthetases were used to charge 
stripped rabbit liver tRNA with L-[35S] methionine, 
specific activity 190 Ci/mmole, as previously describ- 
ed [9]. Analysis of the charged tRNA preparations 
has previously shown [9] that it consists almost ex- 
clusively of met-tRNAmf*. 
2.6. Formation of 80 S ribosome initiation complex 
0.39 A260 units of 0.5 M KCl washed 40 S and 
0.62 A260 units of 60 S ribosomal subunits derived 
from Krebs ascites cells were incubated in 1 ml of a 
solution containing as final concentrations 80 mM 
KCl, 35 mM Tris-Cl buffer, pH 7.2 at 2O”C, 3 mM 
magnesium acetate, 1 mM dithiothreitol, 0.1 mM 
EDTA, 10 @g of a 1: 1: 1 random copolymer of poly 
(A,U,G), 0.1 mM GTP, 2.5 X 10’ cpm of L-[35S] 
met-tRNAmp and 40 ,ul of reticulocyte 0.5 M KCl 
ribosomal wash. After 10 min incubation at 36”C, 
the mixtures were cooled to 0°C and 0.65 ml was 
layered on to a 4.5 ml linear 1 O-30% sucrose gradient 
made up in the incubation buffer. The gradients 
were centrifuged for 45 min at 50 000 rev/mm and 
2°C in a Spinco S.W. 50.1 rotor. The gradients were 
eluted by piercing a hole in the bottom of the tubes 
and 11 drop (350 4) fractions were collected. 200 fl 
of each fraction was pipetted on to 2.5 cm Whatman 
GF/C filter discs in successive 50 fi aliquots. The 
filters were dried thoroughly before counting in a 
liquid scintillation counter. 
T-2 toxin and cycloheximide were dissolved in di- 
methylsulphoxide and water respectively. Final con- 
centrations of dimethylsulphoxide in experimental 
reaction mixtures were always less than 1% (v/v). In 
control experiments dimethylsulphoxide id not con- 
tribute to any of the effects reported here. Puromycin 
dihydrochloride was obtained from the Nutritional 
Biochemical Corporation, Cleveland, Ohio, USA. 
Poly(A,U,G) was purchased from P.L. Biochemicals, 
Milwaukee, Wisconsin, USA. All radioactive chemicals 
were purchased from the Radiochemical Centre 
(Amersham, England). 
3. Results and discussion 
In HeLa cells and in yeast spheroplasts addition of 
T-2 toxin caused rapid and almost complete breakdown 
of polyribosomes [3]. This was the main indication that 
T-2 toxin acts at the level of initiation since the effect 
was paralleled by a rapid inhibition of protein synthesis 
which became apparent shortly after addition of the drug. 
Here we have used the reticulocyte cell-free system to 
study the effect of T-2 toxin on protein synthesis, in 
vitro, since this system has been relatively well-charac- 
terized and thus provides a means to examine some of 
the individual steps involved in the initiation process 
[lo]. Prior to the present work, there had been no 
detailed investigation of the effects of trichothecenes 
upon polypeptide chain initiation nor indeed was there 
any evidence that any of these compounds electively 
inhibit chain initiation in vitro. 
In fg 1 the effect of adding different trichothecenes 
to a reticulocyte lysate synthesizing protein is illustrat- 
ed. Uptake of valine into protein normally proceeds 
linearly for approximately 5min before the curve tails 
off. Addition, after 2 min incubation, of T-2 toxin 
(80 pgjml) has no effect on protein synthesis for about 
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Fig.1. The effect of T-2 toxin on protein synthesis in reti- 
culocyte lysates. The assay mixture, prepared as described 
in materials and methods, was incubated at 36°C. After 
2 min (indicated by the arrow in the diagram) the inhibitors, 
dissolved in dimethylsulphoxide for T-2 toxin and water for 
cycloheximide, were added to the incubation. An equivalent 
volume of dimethylsulphoxide was added to the control. 
Aliquots of the reaction mixtures were removed at the times 
indicated and processed and counted as described in 
materials and methods. (e-e-e) control; (o-o-o) T-2 
toxin; (=-m-m) cycloheximide (1.6 mg/ml final concentra- 
tion), with trichodermin (40 pg/ml final concentration) 
identical points were obtained. 
60 set but then protein synthesis i  inhibited abruptly. 
This lag is absolutely reproducible and is significant. 
Such kinetics of inhibition are consistent with the idea 
that T-2 toxin (an I-type inhibitor in vivo) inhibits the 
initiation of protein synthesis and allows those riboso- 
mes already synthesizing protein at the time of drug 
addition to complete their translation cycles. In contrast, 
trichodermin (an E-type inhibitor invivo) inhibited simi- 
lar systems promptly, with no suggestion of a lag, in 
keeping with the notion that this drug blocks polypep- 
tide chain elongation. Inhibition by cycloheximide, a
known inhibitor of peptide chain elongation, follows 
identical kinetics to those shown by trichodermin. 
The foregoing results establish, for the first time, 
that the trichothecene antibiotics inhibit protein syn- 
thesis in vitro in a manner analogous to that observed 
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in vivo and they support he division of these compounds 
into distinct functional types [3]. Chemically, however, 
the compounds are very similar, and whether or not the 
nature of substituents on carbon-l 5 is responsible for 
determining their precise modes of action [3], it seems 
likely that the various compounds within this group 
will bind to the same ribosomal site(s). In other hands 
[2] a number of trichothecenes, comprising both E- 
types and I-types, behaved similarly in inhibiting 
puromycin-dependent release of N-acetyl eucine from 
aminoacyl-oligonucleotide ‘fragments’ (ACCA-1euAc) 
of tRNA in the presence of human tonsil ribosomes. 
Furthermore [6], the release, by puromycin, of nascent 
peptides from polyribosomes derived from rat liver was 
inhibited by trichodermin (and other E-type inhibitors). 
We, therefore, considered it important o investigate the 
effects of T-2 toxin upon pyromycin reactions utilising 
Table 1 
Release of nascent chains from washed reticulocyte 
polyribosomes by puromycin 
a) 
b) 
cl 
d) 
d 
% nascent chains released 
Control - no incubation 
Control incubated for 10 
min at 37°C 
0 
5 
Control incubated for 10 min 
at 37°C with T-2 toxin 
(40 erg/ml) 
0 
Control incubated for 10 min 
at 37°C with puromycin 
(1 mglml) 
68 
Control incubated for 1 min 
at 37°C with T-2 toxin (40 
fig/ml) followed by a further 
9 min incubation at 37°C 
with puromycin (1 mg/ml) 
64 
The nascent chains on reticulocyte polyribosomes were label- 
led by incubating 2 ml of reticulocyte lysate for 2 min at 37°C 
as described in section 2.2. After the incubation, the mixture 
was cooled to O’C and layered over 6 ml of 20% sucrose made 
up in 20 mM Tris-Cl buffer, pH 7.2, 3 mM magnesium acetate, 
1 mM dithiothreitol, 0.1 mM EDTA and 500 mM KCl. Washed 
polyribosomes were collected by centrifugation at 45 000 
rev/min for 2 hr in a Spinco Ti50 rotor. The pellets obtained 
were rinsed twice with incubation buffer (section 2.2.) and 
resuspended in the same buffer to a final concentration of 
22&e units/ml and 1.5 X 10s cpm/ml. 4.5 X 10” cpm of 
washed polyribosomes were incubated as described above. 
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reticulocyte polyribosomes and the results are given in 
table 1. Again, there was evidence to support a clear 
division of the trichothecenes into two groups; T-2 
toxin failed to inhibit peptide release in this system 
whereas trichodermin, as shown previously, almost 
totally prevented release [6]. 
Because of the failure of T-2 toxin to inhibit peptide 
bond formation with polyribosomes we examined the 
effect of the drug on the initiation of protein synthesis. 
In reticulocyte cell-free protein synthesizing systems 
the initiation process involves several well-defined 
steps [lo] which end with the formation of an 80 S 
ribosome to which met-tRNAmet is bound in the P 
site. We have studied the effect of T-2 toxin on the 
reaction which can take place between puromycin 
and this bound met-tRNAm$, a reaction in many ways 
analogous to the first peptide bond formation in pro- 
tein synthesis. In fig.2(b) we show that T-2 toxin does 
not prevent the formation of an 80 S initiation complex 
containing met-tRNAm$ (and also, by inference, 
mRNA) although such a complex formed in the 
presence of T-2 toxin does not react with puromycin 
(fig.2d). It is possible that an aberrant 80 S complex 
was formed in the presence of T-2 toxin. Alternatively 
T-2 toxin could inhibit the puromycin reaction per se 
(i.e. the peptidyl transferase reaction). In the control 
(fig.2c) incubation of 80 S initiation complexes with 
puromycin alone released approximately 75% of the 
35S-labelled methionine. To distinguish between the 
two possibilities outlined above an 80 S initiation 
complex was formed as described in fIg.2(a). T-2 
toxin and puromycin were then added simultaneously 
and the incubation continued for a further 5 min. 
The result was identical to that shown in fig.2(d). 
Thus, we conclude that T-2 toxin inhibits peptidyl 
transferase directly. In fig.2(c) there is a pronounced 
radioactive peak in the 40 S region of the gradient. 
This may represent complexes formed between 35 S- 
labelled met-tRNAmff and 40 S ribosomal subunits 
generated during puromycin treatment. For some 
reason such complexes do not combine with 60 S 
subunits. 
We deduce from the above experiments that T-2 
toxin inhibits polypeptide chain initiation, not by 
preventing the assembly of the 80 S initiation com- 
plex but by preventing the formation of the first 
peptide bond in the protein synthetic cycle. Since 
trichodermin inhibits peptidyl transferase reactions 
in general [2,6] we consider that T-2 toxin probably 
acts on the same enzymic centre presumably by 
binding to the same ribosomal site(s) as trichodermin. 
Support for this supposition comes from the recent 
work of Schindler [6] who showed that verrucarin A 
(a) tb) 
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Fig. 2. The effect of T-2 toxin on the puromycin-induced 
release of methionine from tRNAmft bound to 80 S ribosome 
complexes. The assay was performed as described in Materials 
and methods. a) Control 10 min incubation; b) T-2 toxin 
(40 ng/ml final concentration) added at zero time and the 
incubation was for 5 min; c) control samples were incubated 
for 5 min before addition of puromycin (1 mg/ml final con- 
centration) and reincubation for a further 5 min; d) T-2 toxin 
(40 fig/ml) added at zero time and the mixture incubated for 
5 min before addition of puromycin (1 mg/ml) and reincuba- 
tion for a further 5 min. (e-e-*) s5 S-radioactivity; (o-o-o) 
superimposed position of an absorbancy profile (A,,,) from 
an identical gradient to show sedimentation position of 80 S 
ribosome monomers. This gradient contained 0.3 A*$,, units 
of 40 S and 0.7 A,,, units of 60 S ribosomal subunits. Under 
the salt conditions of the gradient 80 S monomers form and 
the excess 60 S subunits atso appear on the absorbancy pro- 
file. For all the graphs the sedimentation is from right to left 
and the position of the 80 S monomer is indicated by the 
arrow. A further experiment was carried out in which T-2 
toxin and puromycin were added simultaneously to a control 
complex formed over 5 min incubation. After a further 5 
min incubation a result identical to the one shown in d) was 
obtained. 
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(an I-type inhibitor) and trichodermin share, at least References 
in part, a common ribosomal binding site. Since T-2 
toxin falls to inhibit peptidyl transferase r actions on 111 
reticulocyte polyribosomes (which possess nascent 
peptides of various lengths) we consider that our data 121 
is best explained according to the earlier hypothesis 
[3] whereby the presence (in the ribosomal P site) of 
]31 
oligopeptidyl-tRNA of an undefined but critical, (41 
minimum chain length can prevent he ribosomal 
binding of I-type trichothecenes. Apparently this -I ICl 
binding is not prevented by the presence of met-tRNAmp 
in the P site. The first peptide bond formation in protein 
synthesis need not, however, be a reaction uniquely 
inhibited by T-2 toxin and the second, third etc. peptide 
bond-forming steps may be sensitive to the drug. 
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